In the DEN model of experimental HCC, NFκB activity in hepatocytes protects from cancer development, whereas the activation of this pathway in the bone marrow derived cells promotes cancer development and progression6–8. The gene discussed is NFKB1; the disease is hepatocellular carcinoma.